Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹26,825.3 Cr -3.1% -12.8% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.1%

-12.8%

1%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses